is commissioned considering the introduction of funding mechanisms for late stage clinical development knew that the diseases such
Is the Commission considering the introduction of competitive funding mechanisms for the late-stage clinical development of innovative new vaccines that address the neglected diseases, such as TB?
Is Commission considering the introduction of funding mechanisms for late-stage clinical development new that the diseases, such